Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,524 | 9,985 | 14,489 | 15,104 | 17,202 |
| Marketable Securities | 867 | 869 | 923 | 980 | 1,198 |
| Other current assets | 473 | 548 | 376 | 634 | 984 |
| TOTAL | $7,864 | $11,402 | $15,788 | $16,718 | $19,384 |
| Non-Current Assets | |||||
| PPE Net | 119 | 139 | 154 | 156 | 179 |
| Intangibles | 27,842 | 28,044 | 28,044 | 28,044 | 28,044 |
| Other Non-Current Assets | 240 | 278 | 316 | 354 | 392 |
| TOTAL | $28,201 | $28,461 | $28,514 | $28,554 | $28,615 |
| Total Assets | $36,065 | $39,863 | $44,302 | $45,272 | $47,999 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,187 | 6,278 | 6,995 | 6,042 | 4,692 |
| Other current liabilities | 1,099 | 2,046 | 2,518 | N/A | N/A |
| TOTAL | $6,468 | $8,510 | $9,701 | $6,220 | $4,876 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 230 | 281 | 288 | 399 | 400 |
| TOTAL | $220 | $262 | $304 | $333 | $378 |
| Total Liabilities | $6,688 | $8,772 | $10,005 | $6,553 | $5,254 |
| Shareholders' Equity | |||||
| Retained earnings | -143,620 | -141,215 | -137,453 | -132,627 | -127,589 |
| Other shareholders' equity | 37,400 | 38,610 | 38,566 | 38,322 | 38,089 |
| TOTAL | $29,377 | $31,091 | $34,297 | $38,719 | $42,745 |
| Total Liabilities And Equity | $36,065 | $39,863 | $44,302 | $45,272 | $47,999 |